Singla Neeraj, Shantan Venishetty, Saraswat Anushka, Singh Aniruddha Pratap
Department of Medical Gastroenterology, Fortis Hospitals, Ludhiana 141123, Punjab, India.
Department of Hepatology, AIG Hospitals, Hyderabad 500032, Telangāna, India.
World J Hepatol. 2025 Aug 27;17(8):107679. doi: 10.4254/wjh.v17.i8.107679.
Portal hypertension is a critical determinant of prognosis in chronic liver disease and a key factor in evaluating candidates for liver transplantation. Traditional methods such as hepatic venous pressure gradient (HVPG) measurement have long been considered the gold standard for assessing portal pressure. However, these methods are invasive and carry procedural limitations. Recent advances in endoscopic ultrasound (EUS)-guided techniques have emerged as promising alternatives, offering direct and minimally invasive assessment of portal pressure. EUS-guided portal pressure gradient measurement enables real-time evaluation of haemodynamic through direct access to the portal system. This technique has shown to be as accurate as HVPG, and it has some extra benefits, like the ability to take liver biopsies and check collateral circulation all at the same time. Despite these benefits, the technique poses challenges such as operator dependence, procedural complexity, and limited standardization across centres. This minireview highlights the evolution of portal pressure measurement, focusing on the potential of EUS-guided techniques in pre-transplant assessment, risk stratification, and monitoring therapeutic outcomes. Furthermore, it discusses the technical challenges, clinical implications, and future directions for integrating these innovations into routine practice. Advances in portal pressure measurement hold significant promise for enhancing decision-making and outcomes in liver transplantation.
门静脉高压是慢性肝病预后的关键决定因素,也是评估肝移植候选者的关键因素。长期以来,诸如肝静脉压力梯度(HVPG)测量等传统方法一直被视为评估门静脉压力的金标准。然而,这些方法具有侵入性且存在操作局限性。内镜超声(EUS)引导技术的最新进展已成为有前景的替代方法,可提供对门静脉压力的直接和微创评估。EUS引导的门静脉压力梯度测量能够通过直接进入门静脉系统实时评估血流动力学。该技术已被证明与HVPG一样准确,并且具有一些额外的优势,例如能够同时进行肝活检和检查侧支循环。尽管有这些优势,但该技术也带来了一些挑战,如依赖操作者、操作复杂以及各中心之间标准化程度有限。这篇综述强调了门静脉压力测量的发展,重点关注EUS引导技术在移植前评估、风险分层和监测治疗效果方面的潜力。此外,它还讨论了技术挑战、临床意义以及将这些创新纳入常规实践的未来方向。门静脉压力测量的进展对于改善肝移植的决策制定和治疗效果具有重大前景。